High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal
SETTING: Tribhuvan University Teaching Hospital, Kathmandu, Nepal.OBJECTIVES: 1) To report the number and proportion of Pseudomonas, Acinetobacter, Burkholderia, Stenotrophomonas (PABS) species among intensive care unit (ICU) patients with sputum culture; and 2) to assess antimicrobial resistance pa...
Gespeichert in:
| Veröffentlicht in: | Public health action 2021-11, Vol.11 (1), p.64-69 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 69 |
|---|---|
| container_issue | 1 |
| container_start_page | 64 |
| container_title | Public health action |
| container_volume | 11 |
| creator | Ghimire, R. Gupte, H. A. Shrestha, S. Thekkur, P. Kharel, S. Kattel, H. P. Shrestha, P. S. Poudel, N. Shakya, S. Parajuli, S. Mudvari, A. Edwards, J. |
| description | SETTING: Tribhuvan University Teaching Hospital, Kathmandu, Nepal.OBJECTIVES: 1) To report the number and proportion of Pseudomonas, Acinetobacter, Burkholderia, Stenotrophomonas (PABS) species among intensive care unit (ICU) patients with sputum culture;
and 2) to assess antimicrobial resistance patterns, demographic and clinical characteristics associated with resistance to at least one antibiotic and ICU discharge outcomes among those patients with PABS species admitted to hospital between 14 April 2018 and 13 April 2019.DESIGN:
This was a hospital-based, cross-sectional study using secondary data.RESULTS: Of 166 who underwent sputum culture, 104 (63%) had bacterial growth, of which, 67 (64%) showed PABS species. Of the positive cultures, Pseudomonas, Acinetobacter, Burkholderia and Stenotrophomonas
were present in respectively 32 (30.7%), 31 (29.8%), 1 (1%) and 3 (2.8%). Pseudomonas showed a high level of resistance to levofloxacin (61%), cefepime (50%) and amikacin (50%). Acinetobacter was largely resistant to cefepime (95%), imipenem (92%) and levofloxacin (86%). Of the
67 with PABS infection, 32 (48%) died.CONCLUSION: The study showed a high prevalence of Pseudomonas and Acinetobacter and the emergence of Stenotrophomonas in sputum culture samples of ICU patients. This highlights the need for monitoring PABS and associated
resistance patterns to reduce mortality in ICU patients. |
| doi_str_mv | 10.5588/pha.21.0034 |
| format | Article |
| fullrecord | <record><control><sourceid>pubtec_pubme</sourceid><recordid>TN_cdi_pubmed_primary_34778018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ingid>iuatld/pha/2021/00000011/a00101s1/art00011</ingid><sourcerecordid>iuatld/pha/2021/00000011/a00101s1/art00011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c404t-8b8d381bdc898a392e3416dde0a1528c959706f3f9d241442f98a81acccee06a3</originalsourceid><addsrcrecordid>eNp1kc1v1DAQxSMEolXpiTvyEQnt4q9snAsSVPRDquAAnEezziTrKnGC7awKfz3ObqnKgTnYI89Pb578iuK14OuyNOb9tMO1FGvOlX5WnEop-cqoSj5_0p8U5zHe8VwbLoWRL4sTpavKcGFOi92163asCXPHAkUXE3pLDIfRd-wq4LDy1GFye2JbtImCQ-Y8i9Oc5oFFHKaeImvDODD0eZLIxwW2GIjN3qWF_kIT9q-KFy32kc4f7rPix-Xn7xfXq9uvVzcXH29XVnOdVmZrGmXEtrGmNqhqSUqLTdMQR1FKY-uyrvimVW3dSC20lm3GjEBrLRHfoDorPhx1p3k7UGPJp4A9TMENGH7BiA7-nXi3g27cgymrUlV1Fnj7IBDGnzPFBIOLlvoePY1zBJkdGK6NqTL67ojaMMYYqH1cIzgs8UCOB6SAJZ5Mv3nq7JH9G0YGvh0B57tsDuFunIPPnwXOgpsx9Q0sqS6hwl4IL-4FyJxpLg5clwYaanHuEyQM0P2GKERW_fQ_1aPkwSM_uFxKCMB8chFzE9LhRf0BqCC-JQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2597804887</pqid></control><display><type>article</type><title>High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ghimire, R. ; Gupte, H. A. ; Shrestha, S. ; Thekkur, P. ; Kharel, S. ; Kattel, H. P. ; Shrestha, P. S. ; Poudel, N. ; Shakya, S. ; Parajuli, S. ; Mudvari, A. ; Edwards, J.</creator><creatorcontrib>Ghimire, R. ; Gupte, H. A. ; Shrestha, S. ; Thekkur, P. ; Kharel, S. ; Kattel, H. P. ; Shrestha, P. S. ; Poudel, N. ; Shakya, S. ; Parajuli, S. ; Mudvari, A. ; Edwards, J.</creatorcontrib><description>SETTING: Tribhuvan University Teaching Hospital, Kathmandu, Nepal.OBJECTIVES: 1) To report the number and proportion of Pseudomonas, Acinetobacter, Burkholderia, Stenotrophomonas (PABS) species among intensive care unit (ICU) patients with sputum culture;
and 2) to assess antimicrobial resistance patterns, demographic and clinical characteristics associated with resistance to at least one antibiotic and ICU discharge outcomes among those patients with PABS species admitted to hospital between 14 April 2018 and 13 April 2019.DESIGN:
This was a hospital-based, cross-sectional study using secondary data.RESULTS: Of 166 who underwent sputum culture, 104 (63%) had bacterial growth, of which, 67 (64%) showed PABS species. Of the positive cultures, Pseudomonas, Acinetobacter, Burkholderia and Stenotrophomonas
were present in respectively 32 (30.7%), 31 (29.8%), 1 (1%) and 3 (2.8%). Pseudomonas showed a high level of resistance to levofloxacin (61%), cefepime (50%) and amikacin (50%). Acinetobacter was largely resistant to cefepime (95%), imipenem (92%) and levofloxacin (86%). Of the
67 with PABS infection, 32 (48%) died.CONCLUSION: The study showed a high prevalence of Pseudomonas and Acinetobacter and the emergence of Stenotrophomonas in sputum culture samples of ICU patients. This highlights the need for monitoring PABS and associated
resistance patterns to reduce mortality in ICU patients.</description><identifier>ISSN: 2220-8372</identifier><identifier>EISSN: 2220-8372</identifier><identifier>DOI: 10.5588/pha.21.0034</identifier><identifier>PMID: 34778018</identifier><language>eng</language><publisher>France: International Union Against Tuberculosis and Lung Disease</publisher><subject>Acinetobacter ; Amr ; Amr Supplement ; Burkholderia ; Pseudomonas ; Sort It ; Stenotrophomonas</subject><ispartof>Public health action, 2021-11, Vol.11 (1), p.64-69</ispartof><rights>2021 The Union.</rights><rights>2021 The Union 2021</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c404t-8b8d381bdc898a392e3416dde0a1528c959706f3f9d241442f98a81acccee06a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575379/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575379/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34778018$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ghimire, R.</creatorcontrib><creatorcontrib>Gupte, H. A.</creatorcontrib><creatorcontrib>Shrestha, S.</creatorcontrib><creatorcontrib>Thekkur, P.</creatorcontrib><creatorcontrib>Kharel, S.</creatorcontrib><creatorcontrib>Kattel, H. P.</creatorcontrib><creatorcontrib>Shrestha, P. S.</creatorcontrib><creatorcontrib>Poudel, N.</creatorcontrib><creatorcontrib>Shakya, S.</creatorcontrib><creatorcontrib>Parajuli, S.</creatorcontrib><creatorcontrib>Mudvari, A.</creatorcontrib><creatorcontrib>Edwards, J.</creatorcontrib><title>High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal</title><title>Public health action</title><addtitle>Public Health Action</addtitle><description>SETTING: Tribhuvan University Teaching Hospital, Kathmandu, Nepal.OBJECTIVES: 1) To report the number and proportion of Pseudomonas, Acinetobacter, Burkholderia, Stenotrophomonas (PABS) species among intensive care unit (ICU) patients with sputum culture;
and 2) to assess antimicrobial resistance patterns, demographic and clinical characteristics associated with resistance to at least one antibiotic and ICU discharge outcomes among those patients with PABS species admitted to hospital between 14 April 2018 and 13 April 2019.DESIGN:
This was a hospital-based, cross-sectional study using secondary data.RESULTS: Of 166 who underwent sputum culture, 104 (63%) had bacterial growth, of which, 67 (64%) showed PABS species. Of the positive cultures, Pseudomonas, Acinetobacter, Burkholderia and Stenotrophomonas
were present in respectively 32 (30.7%), 31 (29.8%), 1 (1%) and 3 (2.8%). Pseudomonas showed a high level of resistance to levofloxacin (61%), cefepime (50%) and amikacin (50%). Acinetobacter was largely resistant to cefepime (95%), imipenem (92%) and levofloxacin (86%). Of the
67 with PABS infection, 32 (48%) died.CONCLUSION: The study showed a high prevalence of Pseudomonas and Acinetobacter and the emergence of Stenotrophomonas in sputum culture samples of ICU patients. This highlights the need for monitoring PABS and associated
resistance patterns to reduce mortality in ICU patients.</description><subject>Acinetobacter</subject><subject>Amr</subject><subject>Amr Supplement</subject><subject>Burkholderia</subject><subject>Pseudomonas</subject><subject>Sort It</subject><subject>Stenotrophomonas</subject><issn>2220-8372</issn><issn>2220-8372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kc1v1DAQxSMEolXpiTvyEQnt4q9snAsSVPRDquAAnEezziTrKnGC7awKfz3ObqnKgTnYI89Pb578iuK14OuyNOb9tMO1FGvOlX5WnEop-cqoSj5_0p8U5zHe8VwbLoWRL4sTpavKcGFOi92163asCXPHAkUXE3pLDIfRd-wq4LDy1GFye2JbtImCQ-Y8i9Oc5oFFHKaeImvDODD0eZLIxwW2GIjN3qWF_kIT9q-KFy32kc4f7rPix-Xn7xfXq9uvVzcXH29XVnOdVmZrGmXEtrGmNqhqSUqLTdMQR1FKY-uyrvimVW3dSC20lm3GjEBrLRHfoDorPhx1p3k7UGPJp4A9TMENGH7BiA7-nXi3g27cgymrUlV1Fnj7IBDGnzPFBIOLlvoePY1zBJkdGK6NqTL67ojaMMYYqH1cIzgs8UCOB6SAJZ5Mv3nq7JH9G0YGvh0B57tsDuFunIPPnwXOgpsx9Q0sqS6hwl4IL-4FyJxpLg5clwYaanHuEyQM0P2GKERW_fQ_1aPkwSM_uFxKCMB8chFzE9LhRf0BqCC-JQ</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Ghimire, R.</creator><creator>Gupte, H. A.</creator><creator>Shrestha, S.</creator><creator>Thekkur, P.</creator><creator>Kharel, S.</creator><creator>Kattel, H. P.</creator><creator>Shrestha, P. S.</creator><creator>Poudel, N.</creator><creator>Shakya, S.</creator><creator>Parajuli, S.</creator><creator>Mudvari, A.</creator><creator>Edwards, J.</creator><general>International Union Against Tuberculosis and Lung Disease</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211101</creationdate><title>High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal</title><author>Ghimire, R. ; Gupte, H. A. ; Shrestha, S. ; Thekkur, P. ; Kharel, S. ; Kattel, H. P. ; Shrestha, P. S. ; Poudel, N. ; Shakya, S. ; Parajuli, S. ; Mudvari, A. ; Edwards, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c404t-8b8d381bdc898a392e3416dde0a1528c959706f3f9d241442f98a81acccee06a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acinetobacter</topic><topic>Amr</topic><topic>Amr Supplement</topic><topic>Burkholderia</topic><topic>Pseudomonas</topic><topic>Sort It</topic><topic>Stenotrophomonas</topic><toplevel>online_resources</toplevel><creatorcontrib>Ghimire, R.</creatorcontrib><creatorcontrib>Gupte, H. A.</creatorcontrib><creatorcontrib>Shrestha, S.</creatorcontrib><creatorcontrib>Thekkur, P.</creatorcontrib><creatorcontrib>Kharel, S.</creatorcontrib><creatorcontrib>Kattel, H. P.</creatorcontrib><creatorcontrib>Shrestha, P. S.</creatorcontrib><creatorcontrib>Poudel, N.</creatorcontrib><creatorcontrib>Shakya, S.</creatorcontrib><creatorcontrib>Parajuli, S.</creatorcontrib><creatorcontrib>Mudvari, A.</creatorcontrib><creatorcontrib>Edwards, J.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Public health action</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghimire, R.</au><au>Gupte, H. A.</au><au>Shrestha, S.</au><au>Thekkur, P.</au><au>Kharel, S.</au><au>Kattel, H. P.</au><au>Shrestha, P. S.</au><au>Poudel, N.</au><au>Shakya, S.</au><au>Parajuli, S.</au><au>Mudvari, A.</au><au>Edwards, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal</atitle><jtitle>Public health action</jtitle><addtitle>Public Health Action</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>11</volume><issue>1</issue><spage>64</spage><epage>69</epage><pages>64-69</pages><issn>2220-8372</issn><eissn>2220-8372</eissn><abstract>SETTING: Tribhuvan University Teaching Hospital, Kathmandu, Nepal.OBJECTIVES: 1) To report the number and proportion of Pseudomonas, Acinetobacter, Burkholderia, Stenotrophomonas (PABS) species among intensive care unit (ICU) patients with sputum culture;
and 2) to assess antimicrobial resistance patterns, demographic and clinical characteristics associated with resistance to at least one antibiotic and ICU discharge outcomes among those patients with PABS species admitted to hospital between 14 April 2018 and 13 April 2019.DESIGN:
This was a hospital-based, cross-sectional study using secondary data.RESULTS: Of 166 who underwent sputum culture, 104 (63%) had bacterial growth, of which, 67 (64%) showed PABS species. Of the positive cultures, Pseudomonas, Acinetobacter, Burkholderia and Stenotrophomonas
were present in respectively 32 (30.7%), 31 (29.8%), 1 (1%) and 3 (2.8%). Pseudomonas showed a high level of resistance to levofloxacin (61%), cefepime (50%) and amikacin (50%). Acinetobacter was largely resistant to cefepime (95%), imipenem (92%) and levofloxacin (86%). Of the
67 with PABS infection, 32 (48%) died.CONCLUSION: The study showed a high prevalence of Pseudomonas and Acinetobacter and the emergence of Stenotrophomonas in sputum culture samples of ICU patients. This highlights the need for monitoring PABS and associated
resistance patterns to reduce mortality in ICU patients.</abstract><cop>France</cop><pub>International Union Against Tuberculosis and Lung Disease</pub><pmid>34778018</pmid><doi>10.5588/pha.21.0034</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2220-8372 |
| ispartof | Public health action, 2021-11, Vol.11 (1), p.64-69 |
| issn | 2220-8372 2220-8372 |
| language | eng |
| recordid | cdi_pubmed_primary_34778018 |
| source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Acinetobacter Amr Amr Supplement Burkholderia Pseudomonas Sort It Stenotrophomonas |
| title | High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A48%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubtec_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20drug%20resistance%20among%20Gram-negative%20bacteria%20in%20sputum%20samples%20from%20an%20intensive%20care%20unit%20in%20Nepal&rft.jtitle=Public%20health%20action&rft.au=Ghimire,%20R.&rft.date=2021-11-01&rft.volume=11&rft.issue=1&rft.spage=64&rft.epage=69&rft.pages=64-69&rft.issn=2220-8372&rft.eissn=2220-8372&rft_id=info:doi/10.5588/pha.21.0034&rft_dat=%3Cpubtec_pubme%3Eiuatld/pha/2021/00000011/a00101s1/art00011%3C/pubtec_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2597804887&rft_id=info:pmid/34778018&rft_ingid=iuatld/pha/2021/00000011/a00101s1/art00011&rfr_iscdi=true |